Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer.

Hu-Lieskovan S, Lisberg A, Zaretsky JM, Grogan TR, Rizvi H, Wells DK, Carroll J, Cummings A, Madrigal J, Jones B, Gukasyan J, Shintaku IP, Slamon D, Dubinett S, Goldman JW, Elashoff D, Hellmann MD, Ribas A, Garon EB.

Clin Cancer Res. 2019 Aug 15;25(16):5061-5068. doi: 10.1158/1078-0432.CCR-18-4275. Epub 2019 May 21.

PMID:
31113840
2.

High response rate to PD-1 blockade in desmoplastic melanomas.

Eroglu Z, Zaretsky JM, Hu-Lieskovan S, Kim DW, Algazi A, Johnson DB, Liniker E, Ben Kong, Munhoz R, Rapisuwon S, Gherardini PF, Chmielowski B, Wang X, Shintaku IP, Wei C, Sosman JA, Joseph RW, Postow MA, Carlino MS, Hwu WJ, Scolyer RA, Messina J, Cochran AJ, Long GV, Ribas A.

Nature. 2018 Jan 18;553(7688):347-350. doi: 10.1038/nature25187. Epub 2018 Jan 10.

3.

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.

Tumeh PC, Hellmann MD, Hamid O, Tsai KK, Loo KL, Gubens MA, Rosenblum M, Harview CL, Taube JM, Handley N, Khurana N, Nosrati A, Krummel MF, Tucker A, Sosa EV, Sanchez PJ, Banayan N, Osorio JC, Nguyen-Kim DL, Chang J, Shintaku IP, Boasberg PD, Taylor EJ, Munster PN, Algazi AP, Chmielowski B, Dummer R, Grogan TR, Elashoff D, Hwang J, Goldinger SM, Garon EB, Pierce RH, Daud A.

Cancer Immunol Res. 2017 May;5(5):417-424. doi: 10.1158/2326-6066.CIR-16-0325. Epub 2017 Apr 14.

4.

Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma.

Nowicki TS, Akiyama R, Huang RR, Shintaku IP, Wang X, Tumeh PC, Singh A, Chmielowski B, Denny C, Federman N, Ribas A.

Cancer Immunol Res. 2017 Feb;5(2):118-126. doi: 10.1158/2326-6066.CIR-16-0148. Epub 2016 Dec 30.

5.

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.

Shin DS, Zaretsky JM, Escuin-Ordinas H, Garcia-Diaz A, Hu-Lieskovan S, Kalbasi A, Grasso CS, Hugo W, Sandoval S, Torrejon DY, Palaskas N, Rodriguez GA, Parisi G, Azhdam A, Chmielowski B, Cherry G, Seja E, Berent-Maoz B, Shintaku IP, Le DT, Pardoll DM, Diaz LA Jr, Tumeh PC, Graeber TG, Lo RS, Comin-Anduix B, Ribas A.

Cancer Discov. 2017 Feb;7(2):188-201. doi: 10.1158/2159-8290.CD-16-1223. Epub 2016 Nov 30.

6.

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S, Torrejon DY, Abril-Rodriguez G, Sandoval S, Barthly L, Saco J, Homet Moreno B, Mezzadra R, Chmielowski B, Ruchalski K, Shintaku IP, Sanchez PJ, Puig-Saus C, Cherry G, Seja E, Kong X, Pang J, Berent-Maoz B, Comin-Anduix B, Graeber TG, Tumeh PC, Schumacher TN, Lo RS, Ribas A.

N Engl J Med. 2016 Sep 1;375(9):819-29. doi: 10.1056/NEJMoa1604958. Epub 2016 Jul 13.

7.

PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A.

Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.

8.

Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer.

Moatamed NA, Nanjangud G, Pucci R, Lowe A, Shintaku IP, Shapourifar-Tehrani S, Rao N, Lu DY, Apple SK.

Am J Clin Pathol. 2011 Nov;136(5):754-61. doi: 10.1309/AJCP99WZGBPKCXOQ.

PMID:
22031314
9.

Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma.

Mendelsohn AH, Lai CK, Shintaku IP, Fishbein MC, Brugman K, Elashoff DA, Abemayor E, Dubinett SM, St John MA.

Am J Otolaryngol. 2012 Jan-Feb;33(1):6-13. doi: 10.1016/j.amjoto.2010.11.018. Epub 2011 Mar 24.

10.

Histopathologic findings of HPV and p16 positive HNSCC.

Mendelsohn AH, Lai CK, Shintaku IP, Elashoff DA, Dubinett SM, Abemayor E, St John MA.

Laryngoscope. 2010 Sep;120(9):1788-94. doi: 10.1002/lary.21044.

PMID:
20803740
11.

Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer.

Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA.

Mod Pathol. 2009 Sep;22(9):1151-9. doi: 10.1038/modpathol.2009.82. Epub 2009 May 29.

12.

Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade.

Ribas A, Comin-Anduix B, Economou JS, Donahue TR, de la Rocha P, Morris LF, Jalil J, Dissette VB, Shintaku IP, Glaspy JA, Gomez-Navarro J, Cochran AJ.

Clin Cancer Res. 2009 Jan 1;15(1):390-9. doi: 10.1158/1078-0432.CCR-08-0783.

13.

Distribution of class I and II human leukocyte antigens in the larynx.

Wang EC, Damrose EJ, Mendelsohn AH, Nelson SD, Shintaku IP, Ye M, Berke GS, Blackwell KE.

Otolaryngol Head Neck Surg. 2006 Feb;134(2):280-7.

PMID:
16455378
14.

Prostate stem cell antigen is overexpressed in prostate cancer metastases.

Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE.

Clin Cancer Res. 2005 Apr 1;11(7):2591-6.

15.

An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.

Hoyer KK, Pang M, Gui D, Shintaku IP, Kuwabara I, Liu FT, Said JW, Baum LG, Teitell MA.

Am J Pathol. 2004 Mar;164(3):893-902.

16.

Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.

Lones MA, Kirov I, Said JW, Shintaku IP, Neudorf S.

Bone Marrow Transplant. 2000 Nov;26(9):1021-4. Review.

17.

Relationship between regional cardiac hyperinnervation and ventricular arrhythmia.

Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen PS, Chen LS.

Circulation. 2000 Apr 25;101(16):1960-9.

PMID:
10779463
18.

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.

Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE.

Oncogene. 2000 Mar 2;19(10):1288-96.

19.

Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype.

Said JW, Shintaku IP, Asou H, deVos S, Baker J, Hanson G, Cesarman E, Nador R, Koeffler HP.

Arch Pathol Lab Med. 1999 Mar;123(3):257-60.

PMID:
10086517
20.
21.

Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas.

Said JW, Pinkus JL, Shintaku IP, deVos S, Matsumura F, Yamashiro S, Pinkus GS.

Mod Pathol. 1998 Jan;11(1):1-5.

PMID:
9556415
22.

Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma.

Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D, Savage A, Shintaku IP, Koeffler HP, Asou H, Pinkus G, Pinkus J, Schrage M, Green E, Berenson JR.

Blood. 1997 Dec 1;90(11):4278-82.

PMID:
9373238
23.

Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.

Lones MA, Lopez-Terrada D, Weiss LM, Shintaku IP, Said JW.

Arch Pathol Lab Med. 1997 Jul;121(7):701-6.

PMID:
9240905
24.

Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.

Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA.

Hum Pathol. 1997 May;28(5):533-9.

PMID:
9158700
26.

Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.

Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.

Cancer Res. 1996 Aug 1;56(15):3570-6.

27.

mdm-2 oncogene expression in non-Hodgkin's lymphomas.

Kawamata N, Miller C, Levy V, Shintaku IP, Koeffler HP, Said JW.

Diagn Mol Pathol. 1996 Mar;5(1):33-8.

PMID:
8919543
28.

20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP.

Cancer Res. 1995 Jul 1;55(13):2822-30.

29.
30.

Bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype.

Lones MA, Pinkus GS, Shintaku IP, Said JW.

Am J Clin Pathol. 1994 Oct;102(4):464-7.

PMID:
7524301
31.
32.

Immunohistochemical analysis of p53 expression in malignant lymphomas.

Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP.

Am J Pathol. 1992 Dec;141(6):1343-8.

33.

A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68)

Binder SW, Said JW, Shintaku IP, Pinkus GS.

Am J Clin Pathol. 1992 Jun;97(6):759-63.

PMID:
1317667
35.

Polymerase chain reaction for bcl-2 in diagnostic lymph node biopsies.

Said JW, Sassoon AF, Shintaku IP, Corcoran P, Nichols SW.

Mod Pathol. 1990 Nov;3(6):659-63.

PMID:
2263590
36.

Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement.

Walts AE, Shintaku IP, Said JW.

Am J Clin Pathol. 1990 Aug;94(2):170-5.

PMID:
2371971
37.
38.
39.

Detection of estrogen receptors with monoclonal antibodies in paraffin sections.

Said J, Shintaku IP.

Am J Clin Pathol. 1988 Jul;90(1):120. No abstract available.

PMID:
3291606
40.

Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis.

Walts AE, Said JW, Shintaku IP.

Am J Clin Pathol. 1988 Jul;90(1):77-80.

PMID:
2455446
44.

Immuno-ultrastructural localization of B-cell-specific monoclonal antibodies B1 and B2.

Said JW, Sassoon AF, Shintaku IP, Chien K, Pinkus GS.

J Histochem Cytochem. 1986 May;34(5):607-11.

PMID:
3517145
45.
46.

Chromogranin as a marker of neuroendocrine cells in cytologic material--an immunocytochemical study.

Walts AE, Said JW, Shintaku IP, Lloyd RV.

Am J Clin Pathol. 1985 Sep;84(3):273-7.

PMID:
3898806
47.

Involucrin in intraepithelial and invasive squamous cell carcinomas of the cervix: an immunohistochemical study.

Sassoon AF, Said JW, Nash G, Shintaku IP, Banks-Schlegel S.

Hum Pathol. 1985 May;16(5):467-70.

PMID:
3886522
48.

Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.

Said JW, Vimadalal S, Nash G, Shintaku IP, Heusser RC, Sassoon AF, Lloyd RV.

Hum Pathol. 1985 Mar;16(3):236-40.

PMID:
3972403
50.

Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study.

Said JW, Sassoon AF, Shintaku IP, Banks-Schlegel S.

J Invest Dermatol. 1984 May;82(5):449-52.

Supplemental Content

Loading ...
Support Center